Ecnoglutide for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 8 registered trials.

Why this status

  1. 5 Apr 2023: Trial started, NCT05813795
  2. 14 Apr 2023: Trial registered, NCT05813795
  3. 4 Feb 2026: Trial registered, NCT07387094
  4. 9 Feb 2026: Trial started, NCT07387094
  5. 25 Feb 2026: Trial registered, NCT07434050
  6. 2 Mar 2026: Trial started, NCT07434050
  7. 29 Jul 2026: Trial registered, NCT07734311
  8. 3 Aug 2026: Trial started, NCT07734311

The trials

NCT05111912: Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity

State
Completed
Phase
Phase 2
People
206 taking part
Started
30 Nov 2021
Primary completion
16 Nov 2022
Arms
Cohort A, Cohort B, Cohort C
Results
None posted
  1. 8 Nov 2021: Trial registered
  2. 30 Nov 2021: Trial started
  3. 20 Dec 2022: Trial completed

NCT05813795: A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity

State
Completed
Phase
Phase 3
People
664 taking part
Started
5 Apr 2023
Primary completion
20 Jun 2024
Arms
C1- XW003 Low Dosage, C2- XW003 Medium Dosage, C3- XW003 High Dosage
Results
None posted
  1. 5 Apr 2023: Trial started
  2. 14 Apr 2023: Trial registered
  3. 10 Oct 2024: Trial completed

NCT07073417: A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)

State
Under way
Phase
Phase 2
People
163 taking part
Started
28 Jul 2025
Primary completion
27 Feb 2027
Arms
XW003
Results
None posted
  1. 18 Jul 2025: Trial registered
  2. 28 Jul 2025: Trial started

NCT07143227: A Study of XW003 Injection in Chinese Adolescents With Obesity

State
Completed
Phase
Phase 1
People
48 taking part
Started
25 Aug 2025
Primary completion
18 Apr 2026
Arms
XW003 Dose 1, XW003 Dose 2, XW003 Dose 3
Results
None posted
  1. 25 Aug 2025: Trial started
  2. 27 Aug 2025: Trial registered
  3. 18 Apr 2026: Trial completed

NCT07387094: A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy

State
Under way
Phase
Phase 3
People
140 planned
Started
9 Feb 2026
Primary completion
16 Dec 2027
Arms
XW003 Injection
Results
None posted
  1. 4 Feb 2026: Trial registered
  2. 9 Feb 2026: Trial started

NCT07434050: A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy

State
Under way
Phase
Phase 3
People
140 planned
Started
2 Mar 2026
Primary completion
19 Jun 2028
Arms
XW003 Injection
Results
None posted
  1. 25 Feb 2026: Trial registered
  2. 2 Mar 2026: Trial started

NCT07734311: A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)

State
Under way
Phase
Phase 3
People
360 planned
Started
3 Aug 2026
Primary completion
31 May 2028
Arms
Ecnoglutide Injection
Results
None posted
  1. 29 Jul 2026: Trial registered
  2. 3 Aug 2026: Trial started

NCT07836270: A Study of Ecnoglutide Injection in Overweight or Obese Chinese Adolescents

State
Not started
Phase
Phase 3
People
192 planned
Started
31 Oct 2026
Primary completion
8 Jun 2028
Arms
Ecnoglutide Injection Dose 1, Ecnoglutide Injection Dose 2, Ecnoglutide Injection Dose 3
Results
None posted
  1. 23 Sep 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Ecnoglutide High Dosage, Ecnoglutide Injection, Ecnoglutide Low Dosage, Ecnoglutide Medium Dosage, XW003, XW003 injection.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.